PMID- 37002778 OWN - NLM STAT- MEDLINE DCOM- 20230719 LR - 20230720 IS - 1365-2133 (Electronic) IS - 0007-0963 (Linking) VI - 189 IP - 2 DP - 2023 Jul 17 TI - Facial involvement is reflective of patients' global perception of vitiligo extent. PG - 188-194 LID - 10.1093/bjd/ljad109 [doi] AB - BACKGROUND: The involvement of visible areas in vitiligo has been found to be correlated with increased psychiatric morbidity. Although multiple tools have been developed to assess vitiligo, no cutoff for improvement or worsening of vitiligo from a patient's perspective has been established. OBJECTIVES: To determine the minimal clinically important difference (MCID) of the Self-Assessment Vitiligo Extent Score (SA-VES) in patients with vitiligo and to evaluate, from the patient's perspective, the importance of the change in the involvement of visible areas (face and hands) in patients' overall perception of disease worsening or improving. METHODS: This was a cross-sectional study in the context of the ComPaRe e-cohort. Adult patients with vitiligo were invited to answer online questionnaires. They completed the SA-VES twice, 1 year apart. In addition, patients answered a 5-point Likert anchor question aimed at assessing their perception of the evolution of the extent of their vitiligo. The MCID was calculated using distribution- and anchor-based approaches. Using ordinal logistic regression, the change of vitiliginous lesions on the face or hands was compared to the overall extent of vitiligo (patches on all body areas). RESULTS: In total, 244 patients with vitiligo were included in the analyses; 20 (8%) were found to have an improvement in their vitiligo. The MCID in worsened patients was equal to a 1.3% body surface area [95% confidence interval (CI) 1.01-1.43] increase in the SA-VES. For participants with improved vitiligo, the MCID was equal to a decrease in total SA-VES of 1.3% (95% CI 0.867-1.697). Patients' perceptions of change in their vitiligo was increased sevenfold when it affected the face vs. the rest of the body. CONCLUSIONS: Changes in the facial SA-VES were highly correlated with patients' impressions of the extent of vitiligo. CI - (c) The Author(s) 2023. Published by Oxford University Press on behalf of British Association of Dermatologists. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. FAU - Merhi, Samar AU - Merhi S AD - Universite Paris-Est Creteil, EpiDermE - Epidemiology in Dermatology and Evaluation of Therapeutics, Creteil, France. AD - Faculty of Nursing and Health Sciences, Notre Dame University - Louaize (NDU), Zouk Mosbeh, Lebanon. FAU - Salameh, Pascale AU - Salameh P AD - School of Medicine, Lebanese American University, Byblos, Lebanon. AD - Institut National de Sante Publique d'Epidemiologie Clinique et de Toxicologie-Liban (INSPECT-LB), Beirut, Lebanon. AD - Department of Primary Care and Population Health, University of Nicosia Medical School, Nicosia, Cyprus. AD - Faculty of Pharmacy, Lebanese University, Hadat, Lebanon. FAU - Abboud, Mounya AU - Abboud M AD - Universite Paris-Est Creteil, EpiDermE - Epidemiology in Dermatology and Evaluation of Therapeutics, Creteil, France. FAU - Seneschal, Julien AU - Seneschal J AD - University of Bordeaux, CNRS UMR5164, ImmunoConCept, Bordeaux, France. AD - Department of Dermatology, Pediatric Dermatology, National Reference Center for Rare Skin Disorders, Hopital Saint-Andre, Bordeaux, France. FAU - Eleftheriadou, Viktoria AU - Eleftheriadou V AD - Walsall Healthcare NHS Trust and The Royal Wolverhampton NHS Trust, University of Birmingham, Birmingham, UK. FAU - Pane, Isabelle AU - Pane I AD - Centre de Recherche Epidemiologie et StatistiqueS (CRESS - Universite Paris Cite, INSERM UMR1153), Paris, France. FAU - Tran, Viet-Thi AU - Tran VT AD - Centre de Recherche Epidemiologie et StatistiqueS (CRESS - Universite Paris Cite, INSERM UMR1153), Paris, France. AD - Centre d'Epidemiologie Clinique - Hopital Hotel-Dieu (AP-HP), Paris, France. FAU - Shourick, Jason AU - Shourick J AD - Department of Epidemiology and Public Health, UMR 1027 INSERM, Toulouse University Hospital, Toulouse, France. FAU - Ezzedine, Khaled AU - Ezzedine K AD - Universite Paris-Est Creteil, EpiDermE - Epidemiology in Dermatology and Evaluation of Therapeutics, Creteil, France. AD - AP-HP, Hopital Henri-Mondor, Service de Dermatologie, Creteil, France. LA - eng PT - Journal Article PL - England TA - Br J Dermatol JT - The British journal of dermatology JID - 0004041 SB - IM MH - Adult MH - Humans MH - *Vitiligo/pathology MH - Cross-Sectional Studies MH - Surveys and Questionnaires MH - Severity of Illness Index MH - Perception COIS- Conflicts of interest The authors declare they have no conflicts of interest. EDAT- 2023/04/02 06:00 MHDA- 2023/07/19 06:42 CRDT- 2023/04/01 04:42 PHST- 2022/08/30 00:00 [received] PHST- 2023/03/27 00:00 [revised] PHST- 2023/03/29 00:00 [accepted] PHST- 2023/07/19 06:42 [medline] PHST- 2023/04/02 06:00 [pubmed] PHST- 2023/04/01 04:42 [entrez] AID - 7098435 [pii] AID - 10.1093/bjd/ljad109 [doi] PST - ppublish SO - Br J Dermatol. 2023 Jul 17;189(2):188-194. doi: 10.1093/bjd/ljad109.